[1. Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.10.1681/ASN.V127154911423586]Search in Google Scholar
[2. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109: II2-II10.10.1161/01.CIR.0000129535.04194.3815173056]Search in Google Scholar
[3. Psychari SN, Sinos L, Iatrou C, Liakos G, Apostolou TS. Relations of inflammatory markers to lipid levels and autonomic tone in patients with moderate and severe chronic kidney disease and in patients under maintenance hemodialysis. Clin Nephrol. 2005;64(6):419-27.10.5414/CNP64419]Search in Google Scholar
[4. Vazquez MA, Jeyarajah DR, Kielar ML, Lu CY. Long-termoutcomes of renaltransplantation: A result of the originalendowment of the donor kidney and the inflammatoryresponse to both alloantigens and injury. Curr Opin NephrolHypertens 2000;9:643-648.10.1097/00041552-200011000-0000911128427]Search in Google Scholar
[5. Gotsman I, Grabie N, Gupta R, et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatorymolecule. Circulation 2006;114:2047-055.10.1161/CIRCULATIONAHA.106.63326317060381]Search in Google Scholar
[6. Martinez-Castelao A, Sarrias X, Bestard O,et al. Arterial elasticity measurement in renal transplant patientsunder anticalcineurin immunosuppression. TransplantProc.2005;37:3788-3790.]Search in Google Scholar
[7. Abedini S, Holme I, Marz W et al. Inflammation in renal transplantation. Clin J Am Soc Nephrol 2009;4:1246-1254.10.2215/CJN.00930209270952119541816]Search in Google Scholar
[8. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.10.1056/NEJMra04343015843671]Search in Google Scholar
[9. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 2004;45:1169-1196.10.1194/jlr.R300019-JLR20015102878]Search in Google Scholar
[10. Nonogaki K, Fuller GM, Fuentes NL,et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 1995;136:2143-2149.10.1210/endo.136.5.77206637720663]Search in Google Scholar
[11. Ettinger WH, Varma VK, Sorci-Thomas M,et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler. Thromb. 1994;14:8-13.]Search in Google Scholar
[12. Dahle DO, Mjøen G, Oqvist B, et al. Inflammation-associated graft loss in renal transplant recipients, Nephrol. Dial. Transplant. 2011;26:3756-3761.]Search in Google Scholar
[13. Levey AS, Bosch JP, Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.10.7326/0003-4819-130-6-199903160-0000210075613]Search in Google Scholar
[14. Levey AS, Green T, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 2000;11:155A]Search in Google Scholar
[15. Akdis M et al. Interleukins, from 1 to 37, and interferon- c: receptors, functions and roles in diseases. J Allergy Clin Immunol. 2011;127(3):701-721.10.1016/j.jaci.2010.11.050]Search in Google Scholar
[16. De Serres SA, Vadivel N, Mfarrej BG, et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 2011;15;91(5):552-559.10.1097/TP.0b013e318205b3c1]Search in Google Scholar
[17. Gyanendra Kumar Sonkar, Sangeeta Singh, Satyendra Kumar Sonkar, Usha Singh, Rana Gopal Singh. Evaluation of serum interleukin 6 and tumour necrosis factor alpha levels, and their association with various non-immunological parameters in renal transplant recipients. Singapore Med J 2013;54(9):511-515.10.11622/smedj.2013174]Search in Google Scholar
[18. Gullestad L, Simonsen S, Ueland T, et al. Possible role of proinflammatory cytokines in heart allograft coronary artery disease. Am J Cardiol 1999;84:999-1003.10.1016/S0002-9149(99)00487-7]Search in Google Scholar
[19. Fernández-Real JM, Broch M, Vendrell J, Rieart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000;85:1334-1339.10.1210/jcem.85.3.655510720087]Search in Google Scholar
[20. Greenberg AS, Nordan RP, McIntosh J,et al. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res. 1992;52:4113-4116]Search in Google Scholar
[21. Hingorani S, Gooley T, Pao E, Sandmaier B, McDonald G. Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant. 2014;49(3):403-409. 10.1038/bmt.2013.197394768424317123]Search in Google Scholar